IS7021A - Nýjar heteróarýlafleiður, framleiðsla þeirra og notkun - Google Patents
Nýjar heteróarýlafleiður, framleiðsla þeirra og notkunInfo
- Publication number
- IS7021A IS7021A IS7021A IS7021A IS7021A IS 7021 A IS7021 A IS 7021A IS 7021 A IS7021 A IS 7021A IS 7021 A IS7021 A IS 7021A IS 7021 A IS7021 A IS 7021A
- Authority
- IS
- Iceland
- Prior art keywords
- production
- heteroaryl derivatives
- disorders
- disorder
- new heteroaryl
- Prior art date
Links
- 125000001072 heteroaryl group Chemical group 0.000 title abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010041250 Social phobia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101036 | 2001-06-29 | ||
| PCT/DK2002/000435 WO2003002556A1 (en) | 2001-06-29 | 2002-06-27 | Novel heteroaryl derivatives, their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS7021A true IS7021A (is) | 2003-11-10 |
| IS2425B IS2425B (is) | 2008-10-15 |
Family
ID=8160598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7021A IS2425B (is) | 2001-06-29 | 2003-11-10 | Nýjar heteróarýlafleiður, framleiðsla þeirra og notkun |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20040248883A1 (is) |
| EP (1) | EP1399438B1 (is) |
| JP (1) | JP2004535449A (is) |
| KR (1) | KR20040019026A (is) |
| CN (1) | CN1310909C (is) |
| AT (1) | ATE312094T1 (is) |
| AU (1) | AU2002344949B2 (is) |
| BG (1) | BG108531A (is) |
| BR (1) | BR0210401A (is) |
| CA (1) | CA2451228A1 (is) |
| CZ (1) | CZ2004156A3 (is) |
| DE (1) | DE60207857T2 (is) |
| DK (1) | DK1399438T3 (is) |
| EA (1) | EA006203B1 (is) |
| ES (1) | ES2252471T3 (is) |
| HU (1) | HUP0400344A2 (is) |
| IL (1) | IL158828A0 (is) |
| IS (1) | IS2425B (is) |
| MX (1) | MXPA03011769A (is) |
| NO (1) | NO326514B1 (is) |
| NZ (1) | NZ529460A (is) |
| PL (1) | PL365249A1 (is) |
| SI (1) | SI1399438T1 (is) |
| SK (1) | SK652004A3 (is) |
| UA (1) | UA75407C2 (is) |
| WO (1) | WO2003002556A1 (is) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100338058C (zh) * | 2001-06-29 | 2007-09-19 | H·隆德贝克有限公司 | 新的吲哚衍生物 |
| US7504395B2 (en) * | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| WO2005005424A1 (en) * | 2003-07-02 | 2005-01-20 | TEVA Gyógyszergyár Részvénytársaság | Aztreonam l-lysine and methods for the preparation thereof |
| US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| US7635696B2 (en) | 2004-11-26 | 2009-12-22 | Janssen Pharmaceutica N.V. | Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity |
| WO2011080341A1 (en) | 2010-01-04 | 2011-07-07 | Enantia, S.L. | Process for the preparation of rivaroxaban and intermediates thereof |
| JP5567208B2 (ja) | 2010-04-12 | 2014-08-06 | ロッテ ケミカル コーポレーション | オレフィン重合用触媒組成物およびこれを用いたポリオレフィンの製造方法 |
| JP5567209B2 (ja) | 2010-04-12 | 2014-08-06 | ロッテ ケミカル コーポレーション | オレフィン重合用担持触媒およびこれを用いたポリオレフィンの製造方法 |
| CN104672364A (zh) | 2010-04-12 | 2015-06-03 | 湖南石油化学株式会社 | 使用包含噻吩稠合的环戊二烯基配体的过渡金属化合物制备烯烃-二烯共聚物的方法 |
| KR100986301B1 (ko) | 2010-04-12 | 2010-10-07 | 아주대학교산학협력단 | 테트라하이드로퀴놀린 유도체로부터 유래한 티오펜-축합고리 싸이클로펜타디에닐 4족 금속 화합물 및 이를 이용한 올레핀 중합 |
| JP5546678B2 (ja) | 2010-04-12 | 2014-07-09 | ロッテ ケミカル コーポレーション | チオフェン−縮合環シクロペンタジエニルリガンドを含む遷移金属化合物を使用したポリプロピレンの製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| CN100338058C (zh) * | 2001-06-29 | 2007-09-19 | H·隆德贝克有限公司 | 新的吲哚衍生物 |
-
2002
- 2002-06-27 CA CA002451228A patent/CA2451228A1/en not_active Abandoned
- 2002-06-27 BR BR0210401-6A patent/BR0210401A/pt not_active IP Right Cessation
- 2002-06-27 UA UA20031211984A patent/UA75407C2/uk unknown
- 2002-06-27 EP EP02742849A patent/EP1399438B1/en not_active Expired - Lifetime
- 2002-06-27 NZ NZ529460A patent/NZ529460A/en unknown
- 2002-06-27 HU HU0400344A patent/HUP0400344A2/hu unknown
- 2002-06-27 SK SK65-2004A patent/SK652004A3/sk unknown
- 2002-06-27 CZ CZ2004156A patent/CZ2004156A3/cs unknown
- 2002-06-27 AU AU2002344949A patent/AU2002344949B2/en not_active Ceased
- 2002-06-27 EA EA200400102A patent/EA006203B1/ru not_active IP Right Cessation
- 2002-06-27 IL IL15882802A patent/IL158828A0/xx unknown
- 2002-06-27 DK DK02742849T patent/DK1399438T3/da active
- 2002-06-27 KR KR10-2003-7017125A patent/KR20040019026A/ko not_active Abandoned
- 2002-06-27 MX MXPA03011769A patent/MXPA03011769A/es active IP Right Grant
- 2002-06-27 JP JP2003508937A patent/JP2004535449A/ja active Pending
- 2002-06-27 ES ES02742849T patent/ES2252471T3/es not_active Expired - Lifetime
- 2002-06-27 PL PL02365249A patent/PL365249A1/xx unknown
- 2002-06-27 AT AT02742849T patent/ATE312094T1/de not_active IP Right Cessation
- 2002-06-27 CN CNB028129946A patent/CN1310909C/zh not_active Expired - Fee Related
- 2002-06-27 DE DE60207857T patent/DE60207857T2/de not_active Expired - Fee Related
- 2002-06-27 WO PCT/DK2002/000435 patent/WO2003002556A1/en not_active Ceased
- 2002-06-27 SI SI200230265T patent/SI1399438T1/sl unknown
- 2002-06-27 US US10/482,764 patent/US20040248883A1/en not_active Abandoned
-
2003
- 2003-11-10 IS IS7021A patent/IS2425B/is unknown
- 2003-12-18 NO NO20035673A patent/NO326514B1/no unknown
-
2004
- 2004-01-14 BG BG108531A patent/BG108531A/bg unknown
-
2007
- 2007-06-05 US US11/758,511 patent/US7393845B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS20120158A3 (en) | Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| PT2090575E (pt) | Inibidores de erbb | |
| WO2002064594A3 (en) | 6-substituted pyrido-pyrimidines | |
| ATE347555T1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
| ATE291024T1 (de) | Neue 4-aminofuropyrimidine und ihre verwendung | |
| SI1626720T1 (sl) | Derivati 4-(2-fenilsulfanil-fenil)-piperidina kotzaviralci ponovnega vnosa serotonina | |
| IS2425B (is) | Nýjar heteróarýlafleiður, framleiðsla þeirra og notkun | |
| ATE282605T1 (de) | 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie | |
| ATE279415T1 (de) | Antidepressiv wirksame azaheterocyclymethyl- derivative von oxaheterocycyl-anellierten (1,4)- benzodioxanen | |
| DE60213576D1 (de) | ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINOi2,3-föCHINOXALIN | |
| ATE277934T1 (de) | Antidepressive azaheterocyclylmethylderivate von 7,8-dihydro-1,6,9-trioxa-3- azacyclopenta(a)naphthalin | |
| PT1635828E (pt) | Derivados de 4-(2-feniloxifenil) piperidina ou de 1,2,3,6-tetrahidropiridina como inibidores da recaptação da serotonina | |
| MXPA03011766A (es) | Novedosos derivados de indol. | |
| EA200501579A1 (ru) | Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина | |
| DE60204882D1 (de) | Zykloalkenylsulfonamidderivate | |
| NO20053562L (no) | Nye aminobenzofenonforbindelser | |
| SE0301796D0 (sv) | New use II | |
| SE0301798D0 (sv) | New use IV |